BRPI0911994A2 - processo para a produção de uma fração de leite enriquecida com iga secretora, produto, e, composição. - Google Patents

processo para a produção de uma fração de leite enriquecida com iga secretora, produto, e, composição.

Info

Publication number
BRPI0911994A2
BRPI0911994A2 BRPI0911994A BRPI0911994A BRPI0911994A2 BR PI0911994 A2 BRPI0911994 A2 BR PI0911994A2 BR PI0911994 A BRPI0911994 A BR PI0911994A BR PI0911994 A BRPI0911994 A BR PI0911994A BR PI0911994 A2 BRPI0911994 A2 BR PI0911994A2
Authority
BR
Brazil
Prior art keywords
composition
production
product
fraction enriched
secretory iga
Prior art date
Application number
BRPI0911994A
Other languages
English (en)
Inventor
Charles Maria Hubert Hensgens
Nanda De Groot
Original Assignee
Health L P W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39811649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0911994(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Health L P W filed Critical Health L P W
Publication of BRPI0911994A2 publication Critical patent/BRPI0911994A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BRPI0911994A 2008-05-15 2009-05-11 processo para a produção de uma fração de leite enriquecida com iga secretora, produto, e, composição. BRPI0911994A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5324408P 2008-05-15 2008-05-15
EP08156217 2008-05-15
PCT/NL2009/050248 WO2009139624A1 (en) 2008-05-15 2009-05-11 Process for producing milk fractions rich in secretory immunoglobulins

Publications (1)

Publication Number Publication Date
BRPI0911994A2 true BRPI0911994A2 (pt) 2015-10-20

Family

ID=39811649

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911994A BRPI0911994A2 (pt) 2008-05-15 2009-05-11 processo para a produção de uma fração de leite enriquecida com iga secretora, produto, e, composição.

Country Status (15)

Country Link
US (1) US8669353B2 (pt)
EP (1) EP2280999B1 (pt)
JP (1) JP5762951B2 (pt)
KR (1) KR101645957B1 (pt)
CN (1) CN102124027B (pt)
AU (1) AU2009247031B2 (pt)
BR (1) BRPI0911994A2 (pt)
CA (1) CA2724444C (pt)
CY (1) CY1119600T1 (pt)
DK (1) DK2280999T3 (pt)
ES (1) ES2644983T3 (pt)
NZ (1) NZ589297A (pt)
PL (1) PL2280999T3 (pt)
RU (1) RU2010151414A (pt)
WO (1) WO2009139624A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
EP2244735A4 (en) 2007-10-02 2011-02-23 Avaxia Biologics Inc ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TUBE
EP2138186A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
IT1405998B1 (it) * 2010-12-09 2014-02-06 Bionest Ltd Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato
JP6062433B2 (ja) * 2011-08-03 2017-01-18 プロラクタ バイオサイエンス，インコーポレイテッド 細菌汚染を低減するためのヒト乳の精密濾過
SG11201400260TA (en) 2011-09-01 2014-03-28 Chugai Pharmaceutical Co Ltd Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
RU2014129753A (ru) * 2011-12-21 2016-02-10 Колгейт-Палмолив Компани Шанхуо и секреторный иммуноглобулин слюны
CN104254542A (zh) 2012-03-09 2014-12-31 瑞士杰特贝林生物制品有限公司 包含分泌-样免疫球蛋白的组合物
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
EP2636681A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
JP6238958B2 (ja) 2012-04-05 2017-11-29 ゴットフリート・ヒムラー 分泌型免疫グロブリン複合体
EP2854848B1 (en) 2012-05-25 2016-10-26 Gottfried Himmler Secretory immunoglobulin deficiency treatment and prophylaxis
US9458230B2 (en) 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof
EP2762490A1 (de) * 2013-01-31 2014-08-06 DMK Deutsches Milchkontor GmbH Verfahren zur Gewinnung von Immunoglobulinen aus Kolostralmilch
US9765151B2 (en) * 2013-03-11 2017-09-19 Cured Inc. Method for producing monoclonal IgA antibody
US9468674B2 (en) 2013-09-24 2016-10-18 Wisconsin Alumni Research Foundation Methods of use of secretory IgA
US11312746B2 (en) 2018-05-17 2022-04-26 Csl Behring Ag Method and system of protein extraction
CN114502582A (zh) * 2019-06-28 2022-05-13 雀巢产品有限公司 包含分泌型IgA和益生菌的组合物
US20230173066A1 (en) 2019-07-23 2023-06-08 Frieslandcampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
US20230002444A1 (en) * 2019-11-20 2023-01-05 Csl Behring Ag Method for extracting a protein from a precipitate and method for precipitating impurities
EP4294214A1 (en) * 2021-02-16 2023-12-27 FrieslandCampina Nederland B.V. Milk with a high immunoglobulin content
WO2023159093A1 (en) * 2022-02-16 2023-08-24 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
CH719882A2 (de) * 2022-07-11 2024-01-15 Babylat Gmbh Vorrichtungen und verfahren zur proteinanreicherung von muttermilch
CN115808400A (zh) * 2023-01-18 2023-03-17 黑龙江飞鹤乳业有限公司 分泌型免疫球蛋白a的检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
EP0047597A1 (en) * 1980-09-04 1982-03-17 Wirsbo Bruks Aktiebolag Improvements in and relating to the testing of pipes
DE3432718C1 (de) 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
EP0673203A1 (en) 1992-12-11 1995-09-27 Immunotec Research Corporation Ltd. Process for producing an undernatured whey protein concentrate
WO1996008155A1 (en) 1994-09-16 1996-03-21 New Zealand Dairy Board Physical separation of casein and whey proteins
AUPP806999A0 (en) 1999-01-08 1999-02-04 Csl Limited Process for purifying immunoglobulins
AU5719600A (en) 1999-07-07 2001-01-30 New Zealand Co-Operative Dairy Company Limited Method of obtaining protein isolates and concentrates from colostrum
US6974573B2 (en) 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
US6875459B2 (en) 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US20040167320A1 (en) 2003-02-24 2004-08-26 Couto Daniel E. Methods of tangential flow filtration and an apparatus therefore
US20060051347A1 (en) * 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
WO2006119560A1 (en) 2005-05-10 2006-11-16 Murray Goulburn Co-Operative Co Limited Immunoglobulin fraction and process therefor

Also Published As

Publication number Publication date
CN102124027B (zh) 2015-01-21
AU2009247031A1 (en) 2009-11-19
PL2280999T3 (pl) 2018-02-28
CN102124027A (zh) 2011-07-13
US20110130545A1 (en) 2011-06-02
KR20110036001A (ko) 2011-04-06
EP2280999B1 (en) 2017-09-06
CY1119600T1 (el) 2018-04-04
ES2644983T3 (es) 2017-12-01
WO2009139624A1 (en) 2009-11-19
DK2280999T3 (da) 2017-11-13
JP5762951B2 (ja) 2015-08-12
EP2280999A1 (en) 2011-02-09
US8669353B2 (en) 2014-03-11
AU2009247031B2 (en) 2014-05-29
KR101645957B1 (ko) 2016-08-05
CA2724444C (en) 2019-11-26
JP2011523410A (ja) 2011-08-11
NZ589297A (en) 2011-12-22
CA2724444A1 (en) 2009-11-19
RU2010151414A (ru) 2012-06-20

Similar Documents

Publication Publication Date Title
BRPI0911994A2 (pt) processo para a produção de uma fração de leite enriquecida com iga secretora, produto, e, composição.
BRPI0812064A2 (pt) Formulação farmacêutica, tabletes, e, processo para a produção de uma formulação farmacêutica
BRPI0919192A2 (pt) Uso de lipídio, composição nutricional, e, processo para a produção de uma composição nutricional
BRPI0909122A2 (pt) métodos para produzir produtos estiráveis.
BRPI0923216A2 (pt) composição de resina, artigo moldado, e, processo para produzir uma composição de resina.
BR112013031916A2 (pt) composição nucicional,uso de uma composição nutricional, processo para a fabricação de uma composição nutricional, e produto
BRPI1011463A2 (pt) processo para fabricação de materiais compósitos.
BRPI0820238A2 (pt) Processo de produção de ácido tereftálico e respectivas composições
EP2121947A4 (en) METHOD FOR PRODUCING POLYHYDROXYALKANIC ACID
BRPI1010581A2 (pt) micro-organismos para a produção de 1,4-butanodiol e métodos relacionados
BR112014030065A2 (pt) processo para produzir uma composição de ácido carboxílico, e. processo para produzir uma corrente de pasta purificada compreendendo fdca.
BR112012009966A2 (pt) Produto de proteína estruturada, produto reestruturado e processo para a produção de um produto de proteína estruturada
BRPI0809278A2 (pt) Processo e dispositivo para a produção de moldes com uma camada de poliuretano.
BRPI0919388A2 (pt) ácido succínico e método para produzir o mesmo.
BR112012015030A2 (pt) composição, processo para produzir uma composição e condutor revestido
BRPI0821303A2 (pt) Fração de tomate, método para produção de fração de tomate e método para adoçar produto alimentício
BRPI0914788A2 (pt) Processo para a produção de um produto intermediário de etexilato de dabigatran
BRPI0818781A2 (pt) Processo para a preparação de uma bebida fermentada
BRPI0918986A2 (pt) Produto doce de chocolate, seu processo de preparação, e aparelho adaptado para produzir referido produto doce de chocolate
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
EP2366741A4 (en) POLYORGANOSILOXANE COMPOSITION, HARDENING PRODUCT FROM THE COMPOSITION AND METHOD FOR PRODUCING THE COMPOSITION
BR112013007239A2 (pt) ''composição de chocolate aerado e processo para fabricação de uma composição de chocolate aerado''.
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0811788A2 (pt) Composição de proteína vegetal, processo para a fabricação de uma composição de proteína vegetal e produto alimentício
BRPI0917345A2 (pt) composição, e, método para produzir uma composição estabilizada.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements